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Staphylococcus aureus can cause life-threatening diseases, and hospital- as well as
community-associated antibiotic-resistant strains are an emerging global public health
problem. Therefore, prophylactic vaccines or immune-based therapies are considered
as alternative treatment opportunities. To develop such novel treatment approaches,
a better understanding of the bacterial virulence and immune evasion mechanisms
and their potential effects on immune-based therapies is essential. One important
staphylococcal virulence factor is alpha-toxin, which is able to disrupt the epithelial
barrier in order to establish infection. In addition, alpha-toxin has been reported to
modulate other cell types including immune cells. Since CD4+ T cell-mediated immunity
is required for protection against S. aureus infection, we were interested in the ability of
alpha-toxin to directly modulate CD4+ T cells. To address this, murine naïve CD4+ T
cells were differentiated in vitro into effector T cell subsets in the presence of alpha-toxin.
Interestingly, alpha-toxin induced death of Th1-polarized cells, while cells polarized under
Th17 conditions showed a high resistance toward increasing concentrations of this
toxin. These effects could neither be explained by differential expression of the cellular
alpha-toxin receptor ADAM10 nor by differential activation of caspases, but might result
from an increased susceptibility of Th1 cells toward Ca2+-mediated activation-induced
cell death. In accordance with the in vitro findings, an alpha-toxin-dependent decrease
of Th1 and concomitant increase of Th17 cells was observed in vivo during S. aureus
bacteremia. Interestingly, corresponding subsets of innate lymphoid cells and γδ T cells
were similarly affected, suggesting a more general effect of alpha-toxin on the modulation
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of type 1 and type 3 immune responses. In conclusion, we have identified a novel
alpha-toxin-dependent immunomodulatory strategy of S. aureus, which can directly act
on CD4+ T cells and might be exploited for the development of novel immune-based
therapeutic approaches to treat infections with antibiotic-resistant S. aureus strains.
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INTRODUCTION
The gram-positive bacterium Staphylococcus aureus is an
extracellular pathogen with the ability to invade and persist
within host cells. S. aureus is known to cause severe infections,
ranging from wound infections, endocarditis, and pneumonia to
sepsis, and still represents a global public health threat due to
its resistance toward various antibiotics (1–5). Although many
attempts have been made, there is currently no vaccine available
that can prevent S. aureus infections in humans. This might
be due to efficient bacterial virulence and immune evasion
mechanisms that enable S. aureus to escape immune surveillance
by the host (6). Unraveling these mechanisms will be crucial for
the development of novel immune-based adjunctive therapies
and more efficient vaccines.
Numerous studies have reported a role of CD4+ T cells in anti-
staphylococcal immunity.While Choi and colleagues have shown
in a mouse model that vaccination with extracellular vesicles
derived from S. aureus mediates protection against lethal lung
infection through the action of IFNγ-producing CD4+ T helper
1 (Th1) cells (7), others have reported a role for both Th1 cells
and IL-17A-producing CD4+ T helper 17 (Th17) cells in vaccine-
mediated protection against S. aureus bloodstream infection
(8). Yet, another study suggested that immunization with a
multicomponent vaccine protected mice in a kidney abscess
model as well as a peritonitis model through the synergistic
action of Th17 cells and antibodies (9). These and other examples
clearly show that, depending on the vaccination approach and the
utilized infection model, different CD4+ effector T cell subsets
can confer protection against S. aureus (10, 11).
S. aureus is producing a variety of extracellular virulence
factors, and for some of these, immunomodulatory properties
have already been described. Toxic shock syndrome toxin 1,
which is one example for a staphylococcal superantigen, is
causing polyclonal T cell activation, resulting in overwhelming
inflammation (12). Other secreted proteins result in allergic
responses or favor regulatory T cell differentiation (13–15). Very
recently, Richardson et al. have shown that staphylococcal
phenol-soluble-modulins inhibit in vivo Th1 and Th17
polarization during systemic S. aureus infection (16). One
major virulence factor of S. aureus is alpha-toxin (aka alpha-
hemolysin, hla), which was first described for its lytic activity
toward rabbit erythrocytes (17). Alpha-toxin is secreted as a
monomer and forms heptameric pores upon binding to the host
cell membrane, resulting in death of the target cell (18). The
initial binding step is mediated by the cellular factor ADAM10,
a disintegrin and metalloproteinase domain-containing
protein 10 (19). At sublytic concentrations, alpha-toxin was
shown to impact signaling pathways in different cell types,
hinting toward modulatory properties besides its cytolytic
activity (19–21).
While previous studies have reported an induction of IFNγ
and IL-17A production by human CD4+ T cells stimulated
with sublytic concentrations of alpha-toxin (22–24), the direct
immunomodulatory activity of alpha-toxin on CD4+ T cell
differentiation was not studied, yet. Thus, we here cultured
naïve CD4+ T cells under polarizing conditions and analyzed
the impact of alpha-toxin on survival, proliferation and
differentiation of the cells. Unexpectedly, we found differential
survival of Th1 and Th17 cells cultured in presence of alpha-
toxin. While death of Th1 cells was dose-dependent, Th17 cells
were more resistant toward alpha-toxin. Mechanistically, we
could rule out an involvement of ADAM10 and caspases. When
we translated these in vitro findings into an in vivo setting, we
observed an alpha-toxin-dependent decrease of Th1 cells and a
concomitant increase of Th17 cells during S. aureus bacteremia.
The finding that corresponding subsets of innate lymphoid cells
(ILCs) and γδ T cells were similarly affected, suggested that S.
aureus has evolved a general strategy to modulate type 1 and
type 3 immune responses in addition to its specific targeting of
Th1 cells.
MATERIALS AND METHODS
Animals
B6.Foxp3tm1(CD2/CD52)Shori mice, Foxp3hCD2 reporter mice on
C57BL/6 background expressing human CD2 (hCD2) under
control of the Foxp3 locus (25), and wildtype C57BL/6J mice
were bred and housed under specific pathogen-free conditions
at the animal facility of the Helmholtz Center for Infection
Research (Braunschweig, Germany). Animals were handled in
accordance with good animal practice as defined by FELASA
and the national animal welfare body GV-SOLAS guidelines.
All animal experiments were approved by the Lower Saxony
Committee on the Ethics of Animal Experiments as well as the
responsible state office (Lower Saxony State Office of Consumer
Protection and Food Safety) under the permit number 33.19-
42502-04-13/1195. For all in vivo experiments, gender- and age-
matched animals were used.
Recombinant S. aureus Proteins
Recombinant alpha-toxin (Pan-genome identifier:
SAUPAN003418000; annotation in S. aureus USA300:
SAUSA300_1058), Lipase (Lip, aka Sal1, pan-genome
identifier: SAUPAN006420000, annotation in S. aureus
USA300: SAUSA300_2603 - lip) and Phospholipase C (Plc;
pan genome identifier: SAUPAN000858000; annotation in
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S. aureus USA300: SAUSA300_99 - plc) (26) were produced
and purified as described before (24). In brief, corresponding
gene sequences of S. aureus strain USA300 were introduced into
an Escherichia coli (E. coli) plasmid (pPR-IBA1) with strep-tag
II (IBA). Following plasmid amplification in E. coli DH5α, the
proteins were overexpressed in E. coli BL21 pLysS. Utilizing
strep-Tactin Superflow columns (IBA) and EndoTrap Red
Columns (Profox), recombinant S. aureus proteins were purified
and LPS contamination minimized.
Antibodies
The following antibody conjugates (all purchased from
BioLegend, eBioscience, or BD Biosciences) were used for flow
cytometry and cell sorting: anti-hCD2-APC (RPA-2.10), anti-
CD3-BV510 (17A2), anti-CD3-APC (17A2), anti-CD4-BV605
(RM4-5), anti-CD4-PE/Cy7 (RM4-5), anti-CD8α-APC (53-6.7),
anti-CD11c-APC (N418), anti-CD19-APC (6D5), anti-CD45R-
APC (RA3-6B2), anti-CD62L-BV605 (MEL-14), anti-CD127-PE
(A7R34), anti-F4/80-APC (BM8), anti-Gr1-APC (RB6-8C5),
anti-γδTCR-FITC (eBioGL3), anti-Ter119-APC (TER-119),
anti-RORγt-PE (AFKJS-9), anti-RORγt-BV421 (Q31-378),
anti-T-bet-PE/Cy7 (4B10), anti-T-bet-PE (4B10), anti-
Gata3-PerCP/eFluor710 (TWAJ), anti-IFNγ-FITC (XMG1.2),
anti-IFNγ-BV785 (XMG1.2), anti-IL-17-PE (eBio17B7), and
anti-IL-17A-APC (TC11-18H10.1). Anti-ADAM10-PE (139712)
was purchased from R&D. Exact staining panels for the different
experimental settings are presented in Table S1. All antibodies
were titrated prior to use to determine optimal concentration
for staining.
Flow Cytometry
Flow cytometry analysis was performed as recently described
(27). Prior to intracellular cytokine staining, cells were incubated
with phorbol 12-myristate 13-acetate (PMA, 10 ng/ml),
Ionomycin (0.5µg/ml), and Brefeldin A (10µg/ml) for 4 h at
37◦C (all Sigma-Aldrich). For detection of cell survival and dead
cell exclusion, cells were incubated with a UV-excitable, fixable
Live/Dead dye (LIVE/DEADTM Fixable Blue Dead Cell Stain Kit,
Life Technologies) for 30min. Surface staining was performed
for 15min on ice in PBS (Gibco) containing 0.2 % bovine serum
albumin (BSA, Sigma-Aldrich). Subsequently, cells were fixed,
permeabilized using the Foxp3 Transcription Factor Staining
Kit (eBioscience) according to the manufacturer’s protocol, and
stained intracellularly for cytokines and transcription factors
for 30min or overnight. For detection of caspase-3/7 activity,
cells were harvested, washed twice with PBS and dead cells were
labeled with a UV-excitable, fixable Live/Dead dye for 30min.
The staining reaction was stopped by washing with PBS/BSA.
Subsequently, 50 µl of CellEvent Caspase-3/7 Green Detection
Reagent (Thermo Fisher) was added to each sample. After 30min
of incubation at 37◦C, cells were kept on ice until acquisition. All
flow cytometry samples were acquired at BD FACS LSR-II SORP
or BD LSR-Fortessa (BD Biosciences), and data were analyzed
with FlowJo R© 9.9.6 (FlowJo, LLC).
In vitro CD4+ T Cell Differentiation
To sort highly pure naïve CD4+ T cells devoid of any Foxp3+
regulatory T cells, we made use of Foxp3hCD2 reporter mice (25).
Single cell suspensions were prepared from spleen and lymph
nodes (LN) by using a 100µm cell strainer, and cleared from
erythrocytes by incubation with ammonium chloride buffer at
room temperature for 3min. In most experiments, CD4+ T
cells were first magnetically enriched by anti-CD4 microbeads
using the autoMACS R© Pro (Miltenyi Biotec). Subsequently,
naïve CD4+ T cells were sorted by fluorescence-activated cell
sorting (FACS) as Foxp3hCD2−CD62LhighCD4+Lin− cells (Lin:
CD8α, CD45R, CD11c, F4/80) utilizing a BD FACSAria-Ilu (BD
Biosciences), BD FACS Aria-II SORP (BD Biosciences) or MoFlo
XDP (Beckman Coulter). In the experiments assessing ADAM10
expression, conventional Foxp3hCD2−CD4+ T cells were isolated
by magnetic-activated cell sorting (MACS). In brief, cells were
first stained with anti-hCD2-APC and subsequently magnetically
separated by anti-APC Microbeads (Miltenyi Biotec) using the
autoMACS R© Pro. Next, CD4+ T cells were sorted from the
hCD2− fraction by anti-CD4 microbeads using the autoMACS R©
Pro. In some experiments, sorted naïve CD4+ T cells were
stained with the proliferation dye CellTraceTM Violet (CTV,
Thermo Fisher Scientific) prior to cultivation. Naïve CD4+ T
cells were cultured in IMDM containing 10 % FCS, 1mM
sodium pyruvate, 50 U/ml Penicillin and Streptomycin, 25mM
HEPES, 50µM beta-mercaptoethanol, and non-essential amino
acids (Gibco Life Technologies and Biochrom AG) (cIMDM),
and 150,000 cells per well were seeded into 96-well flat bottom
plates (Thermo Fisher Scientific) previously coated with 1µg/ml
anti-CD3 (17A2, BioLegend) and 1µg/ml anti-CD28 (37.51,
BioLegend). For polarization into different CD4+ effector T
cell subsets, the following cytokines and antibodies were added:
Th1 – IL-12 (20 ng/ml), anti-IL-4 (10 ng/ml, 11B11); Th17 –
IL-6 (30 ng/ml), TGFβ1 (2 ng/ml), IL-1β (10 ng/ml), anti-IL-
2 (5 ng/ml, JES6-1A12), anti-IFNγ (10 ng/ml, XMG1.2) (all
purchased from BioLegend, BioXCell, Peprotech or R&D).
Furthermore, recombinant S. aureus proteins or Ionomycin
(Sigma-Aldrich) were added to the cultures at indicated
concentrations. GI254023X (10 nM, Sigma Aldrich) was added
to the cultures at day 0, while Q-VD-OPh (Q-VD, 20µM,
MP Biomedicals) was supplied daily. Cells were incubated
for indicated time points. If analyzed later than day 3, cells
were removed from the stimulus on day 3 and transferred
to an uncoated plate. At this step, Th1 cells received IL-2
(5 ng/ml, R&D Systems), and Th17 cells received IL-23 (10 ng/ml,
BioLegend). To analyze the impact of alpha-toxin on already
differentiated effector T cells, Th1 and Th17 cells were generated
as described above. On day 5, cells were harvested, counted and
either kept in culture (96-well plates) without restimulation or
restimulated in 96-well plates coated with 0.1µg/ml anti-CD3,
1µg/ml anti-CD28. Part of the cells received 1,000 ng/ml alpha-
toxin, and Th1 and Th17 cells were supplemented with IL-2 and
IL-23, respectively. After 24 or 48 h, cell survival was analyzed via
flow cytometry as described before.
Systemic S. aureus Infection
Systemic infection with S. aureus was performed as previously
described (28). In brief, 40ml of Brain Heart Infusion medium
(BHI; Roth) were inoculated with few colonies of wildtype S.
aureus 6850 (hereafter called wildtype) or an isogenic 1hla
mutant (hereafter called 1hla). Following overnight incubation
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at 120 rpm at 37◦C, bacteria were diluted 1:10 in BHI medium
and further cultivated. Every hour, the optical density (OD) at
600 nm was measured until an OD of 0.5 was reached. Bacteria
were washed twice with PBS to remove toxins, resuspended in
PBS and the OD was adjusted to 1. Aliquots of 0.5ml were
prepared and stored at −80◦C until use. Following infection,
serial dilutions were prepared from the remaining bacterial stock
and plated on COL blood agar plates. The plates were incubated
overnight at 37◦C and colony-forming units (CFU) counted the
next day. Female C57BL/6J mice (age 8–16 weeks) were infected
i.v. with 3.5 × 106 CFU of wildtype or 1Hla S. aureus. Body
weight and general health status as well as the occurrence of
superficial lesions were monitored daily for 2 weeks. Animals
were sacrificed and excluded from analysis if weight loss
exceeded 20 %. On day 14 post infection (p.i.), mice were
sacrificed, inguinal LNs and spleens were collected and meshed
through 100µm cell strainers to obtain single cell suspensions
for flow cytometric analysis. Splenocytes were cleared from
erythrocytes by incubation with ammonium chloride buffer at
room temperature for 3min. Cell numbers were counted at
Accuri C6 cytometer (BD Biosciences). Furthermore, blood was
collected and incubated at room temperature for a minimum of
15min, followed by centrifugation at 2,000 g for 10min. Serum
was collected and stored at−20◦C until further processing.
Cytokine/Chemokine Measurement
Serum samples (30 µl diluted 1+1 with sample diluent)
were analyzed with Bio-Plex Pro Mouse Cytokine 23-
plex Assay Kit (Bio-Rad Laboratories) according to the
manufacturer’s instructions.
Statistical Analysis
Graphs were generated and statistical analyses were performed
with Prism 5.0 and 8.2 (GraphPad Software). Comparisons
of more than two groups were carried out by Kruskal-Wallis
test, followed by Dunn’s multiple comparison test. For time-
or concentration-dependent comparison of two groups, Two-
way ANOVA, followed by Bonferroni multiple comparisons, was
applied. P-values below 0.05 were considered significant with ∗p
< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001, ∗∗∗∗p< 0.0001.
Institutional Safety Regulation and
Biosecurity
All work on genetically modified cells and organisms was
carried out in properly regulated laboratories according to
the regulations stipulated by the health and safety executive
of each institution. Pathogens were handled in laboratories
and animal housing facilities registered according to the
German Act on Genetic Engineering and categorized as safety
level 2. Permissions for constructing and handling genetically
engineered cells and organisms were obtained from the
relevant national authorities. Projects, project leaders, and safety
executives were registered to the authorities. Unauthorized
distribution of S. aureus or S. aureus recombinant proteins was
restricted by the following measures: 24 h surveillance of the
institutional premises; electronic access control at the gate, at
each building, and within each building; accordingly labeled
freezers for storage; access for trained staff only; distribution
of pathogens within Germany only to license holders according
to §44 Infection Protection Act and according to the European
Agreement concerning the International Carriage of Dangerous
Goods by Road (ADR) and the IATA Dangerous Goods
Regulation (DGR).
RESULTS
Alpha-Toxin Induces Death of Th1 Cells,
While Th17 Are More Resistant
Sublytic concentrations of alpha-toxin were previously reported
to induce IFNγ and IL-17A production by human CD4+
T cells (22–24), yet the direct immunomodulatory activity
of alpha-toxin on CD4+ T cell differentiation was not
studied, so far. To unravel whether staphylococcal alpha-
toxin can directly modulate CD4+ T cell differentiation, naïve
Foxp3−CD62LhighCD4+ T cells were isolated from Foxp3hCD2
reporter mice and cultured in vitro under Th1- and Th17-
polarizing conditions in antigen-presenting cell-free cultures.
The selected culture conditions resulted in a homogenous
expression of T-bet in Th1-polarized cells and, particularly
during the first days of differentiation, a homogenous expression
of RORγt in Th17-polarized cells (Figures S1A–D). At day 4, a
still early time point of T cell differentiation, substantial fractions
of the cells cultured under Th1- and Th17-polarizing conditions
already showed IFNγ and IL-17A expression, respectively
(Figures S1B,C), in line with recent studies involving in vitro
T cell differentiation cultures (29, 30). From here on, cells
cultured under Th1- and Th17-polarizing conditions will be
referred to as Th1 and Th17 cells, respectively. To assess the
impact of alpha-toxin on CD4+ T cell differentiation, cells were
cultured under Th1- and Th17-polarizing conditions in presence
of increasing concentrations of alpha-toxin, and T cell survival
as well as differentiation was assessed by flow cytometry on
day 4 of the cultures. Interestingly, we observed a differential
impact of alpha-toxin on the survival of Th1 and Th17 cells.
When cultured under Th1-polarizing conditions, increasing
concentrations of alpha-toxin resulted in a dose-dependent
decrease in the frequency of viable cells, while cells cultured
under Th17-polarizing conditions were not affected in their
viability even at high alpha-toxin concentrations (Figure 1A).
Yet, alpha-toxin induced an enhanced proliferation of Th17
cells as indicated by significantly reduced geometric mean
fluorescence intensity (gMFI) of the proliferation dye CTV.
However, proliferation of cells cultured under Th1-polarizing
conditions was only slightly affected, without reaching statistical
significance (Figure 1B and Figures S1B,C). Next, we studied the
impact of alpha-toxin on the differentiation of Th1 and Th17 cells
by measuring the expression levels of the lineage specification
factors T-bet and RORγt, respectively. When gating on the
viable cells at day 4 of the culture, hardly any effect of alpha-
toxin on the expression of the key transcription factors could
be observed (Figure 1C and Figures S1B,C). In contrast, mild
effects could be observed with regard to the expression of effector
cytokines by the two T cell subsets. Here, alpha-toxin resulted in
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FIGURE 1 | Alpha-toxin induces differential survival in Th1 and Th17 cells. Murine naïve CD4+ T cells were differentiated in vitro into Th1 or Th17 cells in presence of
increasing concentrations of alpha-toxin. On day 4 of the culture, cells were analyzed by flow cytometry. (A) Left: Representative contour plots show frequencies of
living cells in indicated cultures. Numbers indicate frequencies of cells in gates. Right: Graph summarizes frequencies of living cells among Th1- (circles) and
Th17-polarized (squares) cells (mean ± SD). (B) gMFI of CellTraceTM Violet indicates proliferation of Th1 (left) and Th17 cells (right) in presence of indicated
concentrations of alpha-toxin. Cells were gated on living CD4+ T cells and data were normalized to the medium control. (C) gMFIs of T-bet expression in Th1 cells (left)
(Continued)
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FIGURE 1 | and RORγt expression in Th17 cells (right) are depicted. Cells were gated on living CD4+ T cells and data were normalized to the medium control. (D)
Frequencies of IFNγ+ cells among Th1 cells (left) and IL-17A+ cells among Th17 cells (right) are depicted. Cells were gated on living CD4+ T cells. (A–D) Data were
pooled from 3–5 independent experiments with technical triplicates. For statistical analysis, Two-way ANOVA, followed by Bonferroni multiple comparisons (A) or
Kruskal-Wallis test, followed by Dunn’s multiple comparison test (B) was applied. gMFI, Geometric mean fluorescence intensity. **p < 0.01, ****p < 0.0001.
slightly increased frequencies of IFNγ+ Th1 cells and IL-17A+
Th17 cells, without reaching statistical significance (Figure 1D
and Figures S1B,C). To rule out any unspecific effects of
the recombinantly produced alpha-toxin, control experiments
with similarly produced recombinant S. aureus proteins were
performed. Neither Lip nor Plc had any impact on Th1 or Th17
cell differentiation with regards to viability (Figure S2A) and
cytokine production (Figure S2B). In summary, CD4+ T cells
cultured under Th1- and Th17-polarizing conditions showed
differential susceptibility toward alpha-toxin, with Th1 cells
being highly susceptible and Th17 cells more resistant to the
toxin-induced cell death.
Increased Cell Death of Th1 Cells in
Response to Alpha-Toxin Does Not Result
From Higher ADAM10 Expression Levels
Secreted monomeric alpha-toxin can bind to ADAM10 on
target cells and subsequently form heptameric pores, leading
to cell death (19). To investigate if the observed differential
susceptibility of Th1 and Th17 cells toward alpha-toxin
is associated with a differential expression of ADAM10,
Foxp3hCD2− conventional CD4+ T cells were differentiated in
vitro into Th1 or Th17 cells and ADAM10 expression was
analyzed daily for 4 days by flow cytometry. On days 3 and 4, Th1
cells displayed slightly higher levels of ADAM10 as compared to
Th17 cells (Figure 2A). To investigate whether this differential
ADAM10 expression would affect alpha-toxin-mediated cell
death, we made use of an ADAM10 inhibitor, GI254023X, which
has been reported to prevent binding of alpha-toxin to ADAM10
in a number of studies (31–34). However, inhibition of ADAM10
by GI254023X did not restore survival of Th1 cells (Figure 2B).
Taken together, we could show that although Th1-polarized cells
express slightly higher levels of ADAM10 when compared to
Th17-polarized cells, the interaction between alpha-toxin and
ADAM10 is not causing the differential survival of Th1 and Th17
cells cultured in presence of alpha-toxin.
Caspase Inhibition Does Not Prevent Death
of Th1 Cells in Response to Alpha-Toxin
It has been reported that human T cells die from programmed
cell death upon short-term exposure to alpha-toxin (35). To
investigate if Th1-polarized cells cultured in presence of alpha-
toxin die from apoptosis, we analyzed the activity of caspase-3/7
in those cells. To this end, naïve CD4+ T cells were differentiated
into Th1 cells in presence of different concentrations of alpha-
toxin. On day 3 of the culture, 1 day before differential survival
of Th1 and Th17 cells cultured in presence of alpha-toxin was
observed, the frequency of caspase-3/7+ (apoptotic) cells was
assessed by flow cytometry. The frequencies of apoptotic cells
were very low in cells cultured in medium control and did
not increase significantly in presence of 1,000 ng/ml alpha-toxin
FIGURE 2 | ADAM10 does not play a role in alpha-toxin-mediated death of
Th1 cells. Murine conventional CD4+ T cells were differentiated into Th1 or
Th17 cells and analyzed for ADAM10 expression by flow cytometry.
Representative histogram and the summarizing graph show expression level of
ADAM10 relative to FMO control. Cells were gated on living cells (A). Murine
naïve CD4+ T cells were differentiated into Th1 cells in presence of indicated
concentrations of alpha-toxin and in presence or absence of the ADAM10
inhibitor GI254023X. On day 4 of the culture, survival of the cells was analyzed
by flow cytometry. Summarizing graph shows frequencies of living cells under
the different conditions (B). Data were pooled from 4–9 independent
experiments with 2–3 technical replicates. For statistical analysis, Two-way
ANOVA, followed by Bonferroni multiple comparisons was applied. gMFI -
Geometric mean fluorescence intensity. *p < 0.05, **p < 0.01.
(Figure 3A). Since caspase activation was only analyzed at one
time point, we were interested to see whether an inhibition of
caspases over the complete time could rescue the Th1-polarized
cells from alpha-toxin-mediated cell death. In accordance with
the low frequencies of apoptotic cells on day 3, the cell survival
could not be rescued by addition of the pan-Caspase inhibitor
Q-VD to the culture (Figure 3B). We could show that Th1-
polarized cells cultured in presence of alpha-toxin express only
low levels of caspases and can furthermore not be rescued from
alpha-toxin-induced cell death via inhibition of caspases.
Th1 Cells Are More Susceptible to
Ionomycin-Mediated Activation-Induced
Cell Death When Compared to Th17 Cells
Alpha-toxin can induce an increase of intracellular Ca2+ levels
(36). To study if Th1 cells show an increased susceptibility toward
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FIGURE 3 | Th1 cells cannot be rescued from alpha-toxin-mediated cell death by Caspase inhibition. Murine naive CD4+ T cells were differentiated into Th1 cells in
presence or absence of alpha-toxin and Caspase 3/7 activity was assessed by flow cytometry on day 3 of the culture. Representative histograms and the
summarizing graph show frequencies of cells with active Caspase 3/7, gated on living cells (A). Murine naïve CD4+ T cells were differentiated into Th1 cells in
presence of indicated concentrations of alpha-toxin and in presence or absence of the pan-caspase inhibitor Q-VD. On day 4 of the culture, survival of the cells was
analyzed by flow cytometry. Summarizing graph shows frequencies of living cells under the different conditions (B). Murine naïve CD4+ T cells were differentiated into
Th1 or Th17 cells in presence of indicated concentrations of Ionomycin. On day 3 of the culture, survival of the cells was analyzed by flow cytometry. Summarizing
graph shows frequencies of living cells under the different conditions (C). Data are pooled from 3–5 independent experiments with technical triplicates. For statistical
analysis, Two-way ANOVA, followed by Bonferroni multiple comparisons was applied. *p < 0.05, ***p < 0.001, ****p < 0.0001.
elevated intracellular Ca2+ levels when compared to Th17 cells,
naïve CD4+ T cells were differentiated into Th1 or Th17 cells
in presence of the Ca2+ ionophore Ionomycin. On day 3 of
the cultures, the frequency of viable cells was determined by
flow cytometry. While the addition of 500 ng/ml Ionomycin to
the cultures resulted in a decreased frequency of viable cells
cultured under Th1-polarizing conditions, cells cultured under
Th17-polarizing conditions remained unaffected (Figure 3C),
suggesting an increased susceptibility of Th1 cells toward Ca2+-
mediated activation-induced cell death. Interestingly, addition
of alpha-toxin during the restimulation of already differentiated
Th17 cells did not result in a decreased frequency of viable cells,
supporting the finding that Th17 cells are resistant to the toxin-
induced cell death. Yet, it could not be confirmed that also already
differentiated Th1 cells display a higher susceptibility toward
alpha-toxin as the rapid and strong activation-induced cell death
that was induced under the applied restimulation conditions
could not be further increased upon addition of alpha-toxin
(Figure S3).
Alpha-Toxin Causes a Reduced Th1 and an
Increased Th17 Response Upon S. aureus
Infection
We have shown that Th1-polarized cells are more susceptible
toward alpha-toxin in vitro when compared to Th17-polarized
cells. To demonstrate a role of the different susceptibilities of
T cell subtypes toward alpha-toxin in vivo, female C57BL/6J
mice were infected i.v. with a S. aureus wildtype strain or an
isogenic 1hla mutant strain. The animals were monitored daily
for a time period of 14 days. Although both groups displayed
similar survival and body weight changes (Figure S4A), animals
infected with S. aureus wildtype had an increased risk to develop
superficial tissue lesions (abscesses) close to their tail base during
the course of infection as compared to animals infected with S.
aureus 1hla (Figure S4A). As expected, sera of infected animals
showed increased levels of various inflammatory cytokines
and chemokines compared to uninfected controls (Figure S5).
Interestingly, no overt differences between animals infected
with S. aureus wildtype and S. aureus 1hla were detected.
However, we observed substantial changes within the CD4+ T
cell compartment 14 days p.i., a time point at which the adaptive
immune response becomes clearly visible. Upon infection with
S. aureus wildtype, RORγt+ (Th17) cells inside spleen and LNs
were significantly increased both in frequencies and numbers,
while the absolute number of T-bet+ (Th1) cells was significantly
decreased in the spleen (Figure 4 and Figure S4B). In animals
infected with S. aureus 1hla, Th1 frequencies and absolute
numbers were similar to uninfected controls in both organs
(Figure 4B). The frequencies and numbers of Th17 cells inside
spleen and LNs were slightly lower in these animals as compared
to S. aureus wildtype-infected animals, albeit not as low as in
uninfected controls (Figure 4C). Of note, total cellularity of the
spleen was similar in all experimental groups, while cell numbers
within LNs were significantly enhanced upon infection with S.
aureus wildtype and to a lesser extent with S. aureus 1hla when
Frontiers in Immunology | www.frontiersin.org 7 August 2020 | Volume 11 | Article 1579
Bonifacius et al. Immunomodulation by Alpha-Toxin
FIGURE 4 | S. aureus alpha-toxin shifts CD4+ helper T cells toward Th17
cells. Female C57BL/6J mice were either left uninfected or infected i.v. with S.
aureus wildtype or 1hla. On day 14 p.i., animals were sacrificed and organs
harvested for flow cytometric analysis. Representative contour plots show
T-bet and RORγt expression among splenic CD4+ T cells (A). Frequencies of
T-bet+ cells among CD4+ T cells in spleen and LNs and their absolute
(Continued)
FIGURE 4 | numbers are depicted (B). Frequencies of RORγt+ cells among
CD4+ T cells in spleen and LNs and their absolute numbers are depicted (C).
Data were pooled from two independent experiments and each dot represents
one animal. For statistical analysis, Kruskal-Wallis test, followed by Dunn’s
multiple comparison test, was applied. *p < 0.05, **p < 0.01, ***p < 0.001.
compared to uninfected controls (Figure S4D). On the level of
effector cytokine expression, for the Th1 lineage no differences
in the frequencies of IFNγ+ cells could be observed in spleen
and LNs (Figures S6A,B), despite the abovementioned decrease
in the number of T-bet+ cells, suggesting a T-bet-independent
IFNγ expression as reported before (37). For the Th17 lineage,
the frequencies of IL-17A+ cells are reflecting the changes of
RORγt+ cells (Figures S6A,C). To conclude, we have found that
alpha-toxin not only has a direct impact on CD4+ T cells in
vitro but can also modulate the CD4+ T cell response in vivo by
promoting Th17 cells and limiting Th1 cells.
Alpha-Toxin Reduces Frequencies of Both
T-bet+ γδ T Cells and Type 1 ILCs, While
Increasing Frequencies of RORγt+ γδ T
Cells in vivo
After having demonstrated that alpha-toxin can modulate CD4+
T cells both in vitro and in vivo, we next aimed to assess if alpha-
toxin is also able to modulate other immune cell types. To this
end, we analyzed the abundance of γδ T cell and ILC subsets
in mice infected with S. aureus wildtype vs. 1hla 14 days p.i.
In spleens of mice infected with S. aureus wildtype, frequencies
of RORγt+ γδ T cells were significantly increased, while T-
bet+ γδ T cells were significantly decreased (Figures 5A,B and
Figure S4B). Similar tendencies were observed for absolute cell
numbers, yet not reaching statistical significance. In animals
infected with S. aureus 1hla, T-bet+ γδ T cell frequencies and
absolute numbers were similar to uninfected controls, while
the RORγt+ subset was slightly, yet not significantly increased
both in frequencies and absolute numbers as compared to
uninfected controls. At the same time, we observed significantly
decreased frequencies and absolute numbers of type 1 ILCs (T-
bet+) in wildtype-infected animals as compared to S. aureus
1hla-infected animals and uninfected controls, while there
was no impact of either infection on type 3 ILCs (RORγt+)
(Figures 5C,D and Figure S4C). Together, we could show that
alpha-toxin is also able to modulate other immune cell types
including γδ T cells and ILCs, suggesting a more general
effect of alpha-toxin on the modulation of type 1 and type 3
immune responses.
DISCUSSION
Alpha-toxin plays a major role during initial steps of infection
by disrupting the epithelial barrier (38). In addition, it can
affect signaling pathways in different cell types, hinting toward
modulatory properties besides its cytolytic activity (19–21).
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FIGURE 5 | S. aureus alpha-toxin has a long-lasting impact on γδ T cells and ILC subsets. Female C57BL/6J mice were either left uninfected or infected i.v. with S.
aureus wildtype or 1hla. On day 14 p.i., animals were sacrificed and organs harvested for flow cytometric analysis. Representative contour plots show T-bet and
RORγt expression among splenic γδ T cells (A). Frequencies (%) and absolute numbers (#) of T-bet+ and RORγt+ cells among γδ T cells in the spleen are depicted
(B). Representative contour plots show T-bet, Gata3, and RORγt expression among splenic ILCs (C). Frequencies and absolute numbers of T-bet+ or RORγt+ ILCs in
the spleen are depicted (D). Data were pooled from two independent experiments and each dot represents one animal. For statistical analysis, Kruskal-Wallis test,
followed by Dunn’s multiple comparison test, was applied. *p < 0.05, **p < 0.01, ***p < 0.001.
While the innate immune response toward alpha-toxin has
been studied in detail in different murine skin and wound
infection models (6), the impact of alpha-toxin on the adaptive
immune system, and more specifically on the differentiation of
CD4+ T cells, is only incompletely understood. In the present
study, we observed a superior resistance of Th17 cells toward
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alpha-toxin-induced cell death when compared to Th1 cells both
in vitro and in vivo. Importantly, corresponding subsets of γδ T
cells and ILCs were similarly affected in vivo, suggesting a more
general effect of alpha-toxin on the modulation of type 1 and type
3 immune responses.
Besides its cytotoxic effect on different cell types, low
concentrations of alpha-toxin have been reported previously to
induce both IFNγ and IL-17A production in human PBMCs
and CD4+ T cells (22–24). However, the CD4+ T cells were a
mixture of memory and naïve CD4+ T cells in all studies, and IL-
17A secretion upon stimulation with alpha-toxin could only be
observed in Th17-polarized cells, suggesting that memory T cells
were most probably the source of IFNγ and IL-17A production
in alpha-toxin-stimulated CD4+ T cells. While we observed a
differential impact of alpha-toxin on the survival of Th1 and
Th17 cells, at the same time, the cytokine production was slightly
enhanced in both subsets in the presence of alpha-toxin. As
shown by Song et al., pore formation by alpha-toxin allows Ca2+
ions to enter the cell and induce downstream signaling (39),
which could explain the abovementioned cytokine production
upon stimulation of human T cells with sublytic concentrations
of alpha-toxin (22, 23). In the same line, enhanced Ca2+ signaling
might result in increased activation-induced cell death in Th1
cells, as these cells were reported to be more susceptible to Ca2+
signaling when compared to Th17 cells due to differential Fas
ligand and c-FLIP expression as well as activity of p38 and ERK
(40–42). Interestingly, we could mimic the differential effects of
alpha-toxin on Th1- and Th17-polarized cells using Ionomycin,
suggesting an increased susceptibility toward Ca2+ signaling in
Th1 cells as mechanism underlying the differential susceptibility
toward alpha-toxin-induced cell death. Yet, we could not observe
a significant induction of caspases-3/7 in Th1-polarized cells
cultured in presence of alpha-toxin, and Th1 cells were not
rescued from alpha-toxin-induced cell death using a pan-caspase
inhibitor, suggesting the involvement of caspase-independent
mechanisms. To shed further light on the impact of alpha-toxin
on Ca2+ signaling throughout the differentiation of Th1 and
Th17 cells, one could utilize one of the described genetically
encoded Ca2+ sensors (43–45).
Another possible explanation for the differential susceptibility
of Th1 and Th17 cells toward alpha-toxin could be the varying
expression levels of ADAM10, the cellular receptor for alpha-
toxin (19). During differentiation, Th1 cells express slightly
higher levels of ADAM10 as compared to Th17 cells. However,
these subtle differences were not responsible for the increased
susceptibility of Th1 cells toward alpha-toxin-induced cell death
as blockade of alpha-toxin binding to ADAM10 by GI254023X
did not significantly alter the survival of these cells. Noteworthy,
ADAM10 is important for binding of alpha-toxin to the cell
membrane at low concentrations, around 10 ng/ml, of the toxin,
while it is not required at higher concentrations (19). It is
tempting to speculate that a different membrane composition of
Th1 and Th17 cells is accounting for the observed susceptibility
toward alpha-toxin, yet this hypothesis needs to be tested in
future experiments.
To assess the impact of alpha-toxin on CD4+ T cells in
vivo, we have utilized a S. aureus bacteremia model, and in
contrast to already published studies involving skin, wound
or pulmonary infection models (46–48), bloodstream infection
with wildtype S. aureus or an isogenic 1hla mutant strain
caused similar disease severity as measured by body weight
and survival, indicating comparable virulence of the two strains
in this setting. Interestingly, we could recapitulate the in vitro
finding by demonstrating a decreased frequency of T-bet+ CD4+
T cells when wildtype-infected were compared to 1hla-infected
animals, while significantly increased frequencies of RORγt+
CD4+ T cells were observed upon infection with both strains.
Interestingly, similar findings were made for γδ T cells, which
are known to develop effector functions already in the fetal
thymus and represent the main source of IL-17 under steady-
state conditions (49–51). Previously, γδ T cells were reported to
be the first andmajor source of IL-17 during S. aureus pneumonia
and surgical site infection, and IL-17-producing γδ T cells were
shown to be crucial for bacterial clearance (52, 53). Another
subset of immune cells, namely ILCs, was also affected by S.
aureus infection, and these effects were in part alpha-toxin-
dependent. ILCs are mainly tissue-resident and, in contrast to
T cells, lack antigen-specific receptors. They are responsive to
various stimuli and are part of the immediate immune response.
The three main subsets of ILCs—type 1, type 2, and type 3 ILCs—
are innate counterparts to Th1, Th2, and Th17 cells, respectively.
They can be identified by the same lineage transcription factors,
and the factors promoting their activation are similar (54).
Although ILCs act early during infection, we observed long-term
effects of systemic S. aureus infection on type 1 ILCs. These cells
were significantly decreased upon infection with S. aureus, and
this effect was dependent on alpha-toxin. Interestingly, no long-
term effects of systemic S. aureus infection on type 3 ILCs could
be observed, while the corresponding subsets of CD4+ and γδ T
cells were strongly affected. It is a possible scenario that type 3
ILCs were affected by the infection only during very early stages
of the infection, and rapidly normalized in their frequencies until
the later time point of analysis.
The molecular mechanism by which alpha-toxin affects T-
bet+ cells among CD4+ T cells, γδ T cells and ILCs in vivo
remains unknown. Also in vivo, alpha-toxin might have a
direct negative effect on the survival of T-bet+ cells. However,
we cannot exclude that alpha-toxin contributes indirectly, e.g.,
through the induction of inflammatory mediators by accessory
cells. In this regard, it has been demonstrated that alpha-toxin
can activate the NLRP3 inflammasome in monocytic cells (20),
leading to production and secretion of IL-1β, which in turn
can amplify Th17 differentiation as well as IL-17 production by
γδ T cells (55). As a consequence, the resulting enhanced IL-
17 production might have an effect on T-bet+ cells, as IL-17
can directly inhibit T-bet expression (56). Yet, in the present
study we did not observe gross differences in systemic levels of
inflammatory cytokines and chemokines, including IL-1β and IL-
17, at day 14 p.i. when S. aureus wildtype and S. aureus 1hla
infected animals were compared. However, we cannot exclude
an impact of alpha-toxin on the induction of inflammatory
mediators at earlier time points.
One question remains: Why does S. aureus produce alpha-
toxin, as it is inducing an anti-bacterial type 3 immune response
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rather than inhibiting it? Firstly, alpha-toxin seems to be very
important during initial steps of infection. In skin, wound
or pulmonary infection models, immune cell infiltration and
tissue damage were enhanced in presence of alpha-toxin, and
its neutralization ameliorated disease severity (46–48, 57). The
tuning of the adaptive immune response later in the infection
process might be the trade-off that results from the differential
responsiveness of the T cell subtypes to the formation of
membrane pores. Secondly, the presence of Th1 cells has
been shown to be critical for vaccine-mediated protection in
different models (7–11, 58). Hence, the production of alpha-
toxin might also be an immune evasion strategy by S. aureus
to target the host’s protective immunity by reduction of Th1
cells. From the host side, induction of IL-17 and subsequent
recruitment of neutrophils is required for clearance of an
S. aureus infection (59–61). On the other hand, patients suffering
from S. aureus bloodstream infection and showing a high IL-
17 immune response are more likely to die as compared to
patients with a lower IL-17 response (62). However, death of
the host is presumably not beneficial for the pathogen, and
systemic infections with S. aureus are rare in comparison to
local infections. Hence, alerting the host’s immune system and
induction of a mild anti-bacterial immune response via secretion
of alpha-toxin might be a strategy to limit local infection and
prevent systemic spread, promoting a long-lasting equilibrium
between the pathogen and the host.
Taken together, we have identified alpha-toxin as a modulator
of CD4+ T cells, γδ T cells, and ILCs, promoting type 3
while limiting type 1 immune responses. The knowledge gained
from this study could be utilized in the future to develop
novel therapeutic strategies against S. aureus or to selectively
modulate immune responses toward type 3 immunity in
different context.
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